<bill session="114" type="h" number="5073" updated="2017-06-02T21:55:53Z">
  <state datetime="2016-04-27">REFERRED</state>
  <status>
    <introduced datetime="2016-04-27"/>
  </status>
  <introduced datetime="2016-04-27"/>
  <titles>
    <title type="short" as="introduced">Ensuring Useful Research Expenditures is Key for Alzheimer's Act</title>
    <title type="short" as="introduced">EUREKA Act</title>
    <title type="official" as="introduced">To establish EUREKA Prize Competitions to accelerate discovery and development of disease-modifying, preventive, or curative treatments for Alzheimer's disease and related dementia, to encourage efforts to enhance detection and diagnosis of such diseases, or to enhance the quality and efficiency of care of individuals with such diseases.</title>
    <title type="display">EUREKA Act</title>
  </titles>
  <sponsor id="412236"/>
  <cosponsors>
    <cosponsor id="412565" joined="2016-11-14"/>
    <cosponsor id="412657" joined="2016-07-05"/>
    <cosponsor id="412627" joined="2016-09-12"/>
    <cosponsor id="400048" joined="2016-05-10"/>
    <cosponsor id="412379" joined="2016-05-24"/>
    <cosponsor id="412600" joined="2016-05-18"/>
    <cosponsor id="412272" joined="2016-05-18"/>
    <cosponsor id="412651" joined="2016-05-18"/>
    <cosponsor id="412193" joined="2016-05-13"/>
    <cosponsor id="412385" joined="2016-05-13"/>
    <cosponsor id="412637" joined="2016-05-18"/>
    <cosponsor id="412420" joined="2016-05-24"/>
    <cosponsor id="400116" joined="2016-04-27"/>
    <cosponsor id="412257" joined="2016-09-06"/>
    <cosponsor id="412529" joined="2016-05-16"/>
    <cosponsor id="412498" joined="2016-11-16"/>
    <cosponsor id="400170" joined="2016-05-19"/>
    <cosponsor id="400199" joined="2016-05-12"/>
    <cosponsor id="400209" joined="2016-05-16"/>
    <cosponsor id="412435" joined="2016-09-06"/>
    <cosponsor id="412557" joined="2016-04-27"/>
    <cosponsor id="412638" joined="2016-05-10"/>
    <cosponsor id="412558" joined="2016-06-20"/>
    <cosponsor id="400271" joined="2016-05-18"/>
    <cosponsor id="400273" joined="2016-05-13"/>
    <cosponsor id="400661" joined="2016-06-13"/>
    <cosponsor id="412192" joined="2016-05-13"/>
    <cosponsor id="400316" joined="2016-05-24"/>
    <cosponsor id="412307" joined="2016-05-25"/>
    <cosponsor id="412489" joined="2016-05-11"/>
    <cosponsor id="412483" joined="2016-05-24"/>
    <cosponsor id="400361" joined="2016-06-07"/>
    <cosponsor id="412186" joined="2016-05-19"/>
    <cosponsor id="412514" joined="2016-05-27"/>
    <cosponsor id="400402" joined="2016-05-17"/>
    <cosponsor id="412214" joined="2016-06-09"/>
    <cosponsor id="400623" joined="2016-05-23"/>
    <cosponsor id="400422" joined="2016-07-18"/>
    <cosponsor id="412211" joined="2016-05-13"/>
  </cosponsors>
  <actions>
    <action datetime="2016-04-27">
      <text>Introduced in House</text>
    </action>
    <action datetime="2016-04-27">
      <text>Sponsor introductory remarks on measure.</text>
      <reference ref="CR E606"/>
    </action>
    <action datetime="2016-04-27" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2016-04-29">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" activity="Referral"/>
    <committee activity="Referral" code="HSIF14" subcommittee="Health" name="House Energy and Commerce"/>
  </committees>
  <relatedbills>
    <bill relation="identical" session="114" type="s" number="2067"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Advisory bodies"/>
    <term name="Aging"/>
    <term name="Department of Health and Human Services"/>
    <term name="Health programs administration and funding"/>
    <term name="Health promotion and preventive care"/>
    <term name="Health technology, devices, supplies"/>
    <term name="Medical research"/>
    <term name="Medical tests and diagnostic methods"/>
    <term name="National Institutes of Health (NIH)"/>
    <term name="Neurological disorders"/>
    <term name="Research administration and funding"/>
  </subjects>
  <amendments/>
  <summary date="2016-04-27T04:00:00Z" status="Introduced in House">Ensuring Useful Research Expenditures is Key for Alzheimer's Act or the EUREKA Act

This bill amends the Public Health Service Act to require the National Institutes of Health (NIH) to establish EUREKA prize competitions to achieve high-priority breakthroughs in Alzheimer's disease and dementia prevention, diagnosis, treatment, and care.

The NIH must: (1) convene an advisory council of nongovernmental experts in Alzheimer's disease and dementia to develop the EUREKA prize competitions, and (2) appoint a panel of judges to evaluate submissions. The council and panel are not subject to the Federal Advisory Committee Act.

Support for EUREKA prize competitions may be provided by private organizations and individuals.</summary>
  <committee-reports/>
</bill>
